[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650675":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":27,"centralContacts":35,"locations":45,"responsibleParty":60,"collaborators":10,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":48,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Penumbra Inc.","INDUSTRY",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Medical Management",null,[12],"Other: Medical Management",{"label":14,"type":10,"description":10,"interventionNames":15},"Endovascular Thrombectomy plus Medical Management",[16,12],"Device: Endovascular Thrombectomy",[18,23],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DEVICE","Endovascular Thrombectomy","Patients will undergo endovascular thrombectomy plus medical management. Patients will be treated with the Penumbra System Reperfusion Catheters. Perioperative and postoperative management will follow established guidelines for the care of stroke patients.",[14],{"type":24,"name":9,"description":25,"armGroupLabels":26,"otherNames":10},"OTHER","All medical management treatment will follow established guidelines for the care of stroke patients. All medical treatments and supportive care will be administered following each participating hospital's routine practice and in accordance with the Instructions for Use for any medication administered.",[14,9],[28,32],{"name":29,"affiliation":30,"role":31},"Alejandro Spiotta, MD","Medical University of South Carolina","PRINCIPAL_INVESTIGATOR",{"name":33,"affiliation":34,"role":31},"Nitin Goyal, MD","University of Tennessee Health Science Center\u002FSemmes Murphey Clinic",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":10,"email":40},"Madeline Turtle","CONTACT","260-224-8231","MTurtle@PENUMBRAINC.COM",{"name":42,"role":38,"phone":43,"phoneExt":10,"email":44},"Jennifer Jelf","510-440-5719","jjelf@penumbrainc.com",[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":10},"Fort Sanders Regional Medical Center","RECRUITING","Knoxville","Tennessee","37916","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-83.92074,35.96064,{"lat":58,"lon":57},{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100650675","forward-functional-outcomes-in-real-world-treatment-and-revascularization-of-non-dominant-and-distal-m2-occlusions-100650675",false,"NCT07749170","FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions","Inclusion Criteria:\n\n1. Participant age ≥ 18\n2. Participant experiencing acute ischemic stroke due to a confirmed primary M2 occlusion in the vertical segment or post-bifurcation in the non-dominant or co-dominant branch of the horizontal segment\n3. NIHSS ≥5 or NIHSS 3-4 with disabling symptoms\n4. Pre-stroke mRS 0-1\n5. For participants undergoing thrombectomy: Planned first-line treatment with Penumbra System reperfusion catheters\n6. Informed consent obtained per Institutional Review Board\u002FEthics Committee requirements\n\nExclusion Criteria:\n\n1. Any stenosis or occlusion in the ICA origin requiring treatment during the procedure or within the 90-day follow-up period.\n2. Known multiple occlusions\n3. Secondary M2 occlusion\n4. Known or high suspicion of underlying ICAD as the cause of the M2 occlusion\n5. Current hospitalization at time of stroke onset and\u002For any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days\n6. Currently participating in an investigational (drug, device, etc.) clinical trial that will influence the endovascular procedure or acute treatment. Participants in secondary prevention, observational, natural history and\u002For epidemiological studies are eligible.\n7. Other medical, behavioral, or psychological conditions that in the opinion of the Investigator could limit the ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study","ALL","18 Years",{"count":71,"type":72},250,"ESTIMATED","OBSERVATIONAL","The objective of this study is to collect safety and effectiveness data on the Penumbra System reperfusion catheters in participants with isolated primary non-dominant and distal M2 occlusions who undergo endovascular mechanical thrombectomy (EVT). Additionally, this study aims to observe characteristics and outcomes of participants treated with medical management (MM) alone and those who receive EVT + MM per current medical practice.",[76,77],"Acute Ischemic Stroke","Acute Ischemic Stroke (AIS) Related to a Distal Occlusion","2026-08-05",{"date":80,"type":81},"2026-08-06","ACTUAL",{"date":83,"type":81},"2026-06-26",{"date":85,"type":72},"2028-09",{"name":5,"class":6},1]